Dow Jones

39,814.84

0.02%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Advanced Accelerator Applications S.A. ADS (delisted) (AAAP)
Advanced Accelerator Applications S.A. ADS (delisted) (AAAP) Noticias

AAAP

ADVANCED ACCELERATOR APPLICATION (AAAP)

Advanced Accelerator Applications S.A. ADS (delisted)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AAAP

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/02/2019	13:06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
03/12/2018	02:00	GlobeNewswire Inc.	Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and c...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
12/02/2018	08:18	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
12/02/2018	06:00	GlobeNewswire Inc.	Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
09/02/2018	12:09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	15:24	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	15:24	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	15:24	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	15:21	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	15:05	GlobeNewswire Inc.	Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	08:02	Edgar (US Regulatory)	(25)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
26/01/2018	11:00	GlobeNewswire Inc.	Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendoc...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
22/01/2018	07:00	GlobeNewswire Inc.	Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
07/12/2017	06:16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
07/12/2017	06:00	GlobeNewswire Inc.	Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
07/12/2017	05:05	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
05/12/2017	15:20	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
05/12/2017	15:00	GlobeNewswire Inc.	Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
24/11/2017	05:01	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
17/11/2017	06:39	GlobeNewswire Inc.	Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	18:46	Dow Jones News	ADRs End Mostly Higher; Advanced Accelerator Applications, Braskem Trade Actively	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	08:00	Dow Jones News	Novartis to Pay $3.9 Billion for Radio-Pharmaceuticals Firm -- Update	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	02:08	Dow Jones News	Novartis to Buy Advanced Accelerator Applications for $3.9 Billion	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	01:00	GlobeNewswire Inc.	Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
29/09/2017	08:16	GlobeNewswire Inc.	Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera®) for Gastroenter...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
06/09/2017	10:03	GlobeNewswire Inc.	CORRECTING and REPLACING -- Advanced Accelerator Applications S.A.	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
06/09/2017	06:00	GlobeNewswire Inc.	Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lute...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
31/08/2017	06:00	GlobeNewswire Inc.	Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
28/08/2017	09:08	GlobeNewswire Inc.	Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
27/07/2017	06:00	GlobeNewswire Inc.	Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)